Vesilute
Vesilut · Khavinson bladder bioregulator
RUSSIAN RESEARCH · KHAVINSON SHORT PEPTIDE BIOREGULATOR
▓ 1 indexed citations across EuropePMC (1).
Citation breakdown by evidence tier
← weaker evidence · stronger evidence →
Tap any tier to jump to that section of the bibliography.
Mechanism of action
Membrane-penetrant Glu-Asp dipeptide; modulates gene expression in bladder urothelium and smooth muscle
Researched effects
Bladder mucosal support; urinary function; smooth muscle regulation
Live evidence
Live signals refreshed daily. Current as of November 19, 2026.
Dosing reported in literature
Oral capsule 1-2x daily
Known concerns
Very limited data; no English-indexed primary literature
Top-ranked picks
1 pre-curated authoritative sources, ranked by journal tier and study weight.
Full citation library
Year distribution
No references match — clear filters.
Research Articles
1-
1.
Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action. The purpose of this review is to systematize the available data on USP transport involving POT and LAT transporters in various organs and tissues under normal, pathological and ageing conditions. The ca…
Curated sources on file
3- 1.
- 2.
-
3.
Note: Vesilute is a Glu-Asp dipeptide bladder bioregulator (Russian transliteration: Vesilut), distinct from Vesugen (Lys-Glu-Asp tripeptide for vascular function). PubMed returns zero hits for 'vesilute' as a search term; primary references are vendor catalogs and Khavinson-laboratory reviews — entry confidence is correspondingly lower.